metformin has been researched along with Thoracic Neoplasms in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Thoracic Neoplasms: New abnormal growth of tissue in the THORAX.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shukla, SK | 1 |
| Chan, A | 1 |
| Parvathaneni, V | 1 |
| Gupta, V | 1 |
1 other study available for metformin and Thoracic Neoplasms
| Article | Year |
|---|---|
Metformin-loaded chitosomes for treatment of malignant pleural mesothelioma - A rare thoracic cancer.
Topics: Antineoplastic Agents; Cell Line, Tumor; Chitosan; Delayed-Action Preparations; Drug Liberation; Hum | 2020 |